The Net Margin of Oncolys Biopharma Inc (4588.T) is -5368.27%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -5368.27% |
| 2023-12-31 | -3075.14% |
| 2022-12-31 | -117.70% |
| 2021-12-31 | -251.43% |
| 2020-12-31 | -666.84% |
| 2019-12-31 | -69.97% |
| 2018-12-31 | -732.04% |
| 2017-12-31 | -476.00% |
| 2016-12-31 | -522.34% |
| 2015-12-31 | -706.73% |